Journal article icon

Journal article

Drug treatments affecting ACE2 in COVID-19 infection: a systematic review protocol.

Abstract:

Background
The SARS-CoV-2 virus causing COVID-19 binds human angiotensin-converting enzyme 2 (ACE2) receptors in human tissues. ACE2 expression may be associated with COVID-19 infection and mortality rates. Routinely prescribed drugs that up- or down-regulate ACE2 expression are, therefore, of critical research interest as agents that might promote or reduce risk of COVID-19 infection in a susceptible population.

Aim
To collate evidence on routinely prescribed drug treatments...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.3399/bjgpopen20x101115

Authors


More by this author
Role:
Author
ORCID:
0000-0003-0175-443X
More by this author
Role:
Author
ORCID:
0000-0002-5610-850X
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Role:
Author
ORCID:
0000-0003-3982-4325
Publisher:
Royal College of General Practitioners
Journal:
British Journal of General Practice Open More from this journal
Volume:
4
Issue:
3
Pages:
bjgpopen20X101115-bjgpopen20X101115
Place of publication:
England
Publication date:
2020-07-14
Acceptance date:
2020-06-02
DOI:
EISSN:
2398-3795
ISSN:
2398-3795
Pmid:
32665234
Language:
English
Keywords:
Pubs id:
1119462
Local pid:
pubs:1119462
Deposit date:
2020-08-25

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP